Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

Homeopathy helped regrow hair in a severe hair loss case.

The new SFS Scale predicts hair transplant difficulty using hair and skin types, with thick skin and coily hair being hardest to work with.

Adalimumab may cause severe hair loss in some patients.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Serum from alopecia patients does not stop hair growth in grafted skin on mice.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

A woman with Kallman's syndrome also developed alopecia universalis, a condition not previously linked to Kallman's.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

HLA-DRB5 and other genes may be linked to alopecia universalis.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Alopecia universalis can be an early sign of HIV.

A specific gene mutation causes congenital hair loss.

PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

The Hairless gene is crucial for healthy skin and hair growth.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Denosumab treatment for osteoporosis can cause hair loss.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.